Poor brain reserve increases mortality risk in glioblastoma
The findings highlight the potential of brain reserve as a new biomarker for brain tumor prognosis and treatment planning and establish significant associations between structural brain-reserve metrics and glioblastoma outcomes, independent of age and KPS.